Ping An Biomedical Co., Ltd.
For the period ended Jul 20, 2026. Filed Jul 20, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jul 20, 2026 · Filed Jul 20, 2026
Use the contents to explore the available documents and sections.
PASW$1.31-17.6%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · BACKGROUND:
BACKGROUND:
| (A) | The Vendor is the holder of certain Intellectual Property as set out in Schedule 3. |
|---|
| (B) | The Purchaser is a wholly owned subsidiary of Ping An Biomedical Co Ltd (“PASW”). |
|---|
| (C) | The Vendor has agreed to sell, and the Purchaser has agreed to buy, the IP Rights (as hereinafter defined) on the terms set out in this Deed. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.